Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization
eLife · 30.04.2025 · 14
DOI: 10.7554/elife.104237.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 30.04.2025. Verfasst von Mia L Abramsson und 13 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Vetenskapsrådet, Svenska Sällskapet för Medicinsk Forskning, Medical Research Council.
Abstract (Originalsprache)
Integral membrane proteins carry out essential functions in the cell, and their activities are often modulated by specific protein-lipid interactions in the membrane. Here, we elucidate the intricate role of cardiolipin (CDL), a regulatory lipid, as a stabilizer of membrane proteins and their complexes. Using the in silico-designed model protein TMHC4_R (ROCKET) as a scaffold, we employ a combination of molecular dynamics simulations and native mass spectrometry to explore the protein features that facilitate preferential lipid interactions and mediate stabilization. We find that the spatial arrangement of positively charged residues as well as local conformational flexibility are factors that distinguish stabilizing from non-stabilizing CDL interactions. However, we also find that even in this controlled, artificial system, a clear-cut distinction between binding and stabilization is difficult to attain, revealing that overlapping lipid contacts can partially compensate for the effects of binding site mutations. Extending our insights to naturally occurring proteins, we identify a stabilizing CDL site within the E. coli rhomboid intramembrane protease GlpG and uncover its regulatory influence on enzyme substrate preference. In this work, we establish a framework for engineering functional lipid interactions, paving the way for the design of proteins with membrane-specific properties or functions.
Förderung
- Vetenskapsrådet
- Svenska Sällskapet för Medicinsk Forskning
- Medical Research Council
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Howard Dalton Centre
- European Regional Development Fund
- Ministerstvo Školství, Mládeže a Tělovýchovy
Zitieren
APA
Abramsson, M. L., Corey, R. A., Skerle, J. L., Persson, L. J., Anden, O., Oluwole, A. O., Howard, R. J., Lindahl, E., Robinson, C. V., Strisovsky, K., Marklund, E. G., Drew, D., Stansfeld, P. J., & Landreh, M. (2025). Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization. eLife, 14. https://doi.org/10.7554/elife.104237.3
Vancouver
Abramsson ML, Corey RA, Skerle JL, Persson LJ, Anden O, Oluwole AO, et al. Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization. eLife. 2025;14. doi:10.7554/elife.104237.3
BibTeX
@article{Abramsson2025,
author = {Abramsson, Mia L and Corey, Robin A and Skerle, Jan L and Persson, Louise J and Anden, Olivia and Oluwole, Abraham O and Howard, Rebecca J and Lindahl, Erik and Robinson, Carol V and Strisovsky, Kvido and Marklund, Erik G and Drew, David and Stansfeld, Phillip J and Landreh, Michael},
title = {Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.104237.3}
}
EUVIMED